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Alexandra CH NowakowskiAbstract
Background: This study explores relationships between chronic inflammation and quality of life, making a case for
biopsychosocial modeling of these associations. It builds on research from social and clinical disciplines connecting
chronic conditions, and inflammatory conditions specifically, to reduced quality of life.
Methods: Data from Wave I of the National Social Life, Health, and Aging Project are modeled using ordinal logistic
and ordinary least-squares regression techniques. Inflammation is measured using C-reactive protein; quality of life
is conceptualized as happiness with life overall as well as intimate relationships specifically.
Results: For most NSHAP participants, chronic inflammation significantly predicts lower odds of reporting high QoL
on both emotional and relational measures. Social structural factors do not confound these associations.
Inconsistent results for participants with very high (over 6 mg/L) CRP measurements suggest additional social
influences.
Conclusions: Findings echo strong theoretical justification for investigating relationships between CRP and QoL in
greater detail. Further research should explore possible mediation of these associations by sociomedical sequelae of
chronic disease as well as social relationship dynamics. Elaboration is also needed on the mechanisms by which
social disadvantage may cause chronic inflammation.
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Research on inflammation has become increasingly wide-
spread throughout the sociomedical sciences in recent
years. New datasets integrating biological data along with
information about other types of health (emotional, be-
havioral, social, etc.) have allowed scholars to explore
questions about how non-biological factors may predis-
pose people to inflammation. Much of this work has fo-
cused on chronic inflammation, which may play a role in
a wide variety of health conditions.
Likewise, researchers have long suspected that these
conditions can shape social opportunities and relation-
ships. Chronic conditions may thus impact quality of life
(QoL) as people move through the experience of livingCorrespondence: xnowakowski@fsu.edu
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unless otherwise stated.with chronic disease. A robust literature on chronic dis-
ease and QoL exists in multiple sociomedical disciplines,
including sociology. Yet comparatively little research ex-
ists on how inflammation itself impacts QoL. Even less re-
search engages biomarker data—rather than diagnosis
status or other clinical indicators—to capture underlying
inflammatory pathology that may influence QoL.
This study contributes to a growing literature on relation-
ships between inflammation and QoL. Specifically, it lays a
foundation for sociological inquiry on inflammatory bio-
markers as determinants of social and emotional health. It
supports more nuanced analyses of inflammation’s influ-
ence on QoL in social context. Likewise, it brings together
literatures from multiple fields to recommend a biopsycho-
social understanding of how inflammation impacts social
life and vice versa.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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The inflammatory biomarker C-reactive protein (CRP) has
a strong evidence basis for use in sociomedical research.
Bodies produce CRP in response to inflammation [1-3].
CRP gets deposited wherever swelling occurs—including
joints, mucous membranes, and muscles [3]. This sub-
stance is generated when inflammation of any type is
present [1,2]. Consequently, it can capture inflammation
from a wide variety of health conditions, even if the person
has no diagnoses [3]. While CRP levels can reflect a certain
amount of acute inflammation, they are particularly good
for capturing chronicity.
Acute inflammation from injury or pathogenic illness
is unlikely to introduce significant differential bias. Ele-
vations in CRP levels from acute inflammation tend to
be not only temporary, but also small [3]. By contrast,
baseline CRP levels are generally stable over time [4].
Average CRP values increase with age, but the relative
distribution of values according to health status remains
largely stable over time [3,4]. Likewise, while baseline
CRP levels cannot be used to diagnose any particular
disease [5], high levels do provide excellent evidence of
generalized inflammation. Elevated levels can also indi-
cate progression of inflammation in people with chronic
conditions [3,5].
High levels of CRP circulating freely in the blood gen-
erally indicate widespread inflammation affecting mul-
tiple tissues [4]. Indeed, researchers have discovered that
levels of freely circulating CRP are determined exclu-
sively by the body’s rate of synthesizing this substance
[6]. Likewise, acute conditions are unlikely to elevate the
synthesis rate substantially or for very long [4]. In fact,
CRP levels often drop rapidly when synthesis stops [4].
CRP thus constitutes a good predictor of chronic inflam-
mation for a variety of different disease populations, des-
pite its inherent limitations.
Only a few published studies have explicitly focused on
the relationship between CRP and QoL [7-9]. While these
studies do not delve deeply into potential psychosocial dy-
namics of the association between CRP and QoL, they do
find that elevated levels of CRP significantly predict di-
minished levels of QoL [7]. An excellent foundation thus
exists for further work on CRP and QoL using generalized
linear modeling techniques. Researchers in a variety of
disciplines can now extend this foundation to more di-
verse outcomes that capture different elements of overall
QoL. Scholars can also explore synergistic effects of bio-
logical and social mechanisms on QoL, and potentially
unique dynamics of these phenomena in older adults.
Given robust linkage in sociological literature between
health status and self-rated QoL [10], a strong theoretical
connection exists between CRP and QoL outcomes.
Although research on CRP specifically as a determinant
of QoL remains largely absent from the literature, researchon chronic inflammatory disease and its relationship to
QoL has expanded greatly within the past 20 years. Sev-
eral researchers have focused on general associations be-
tween specific inflammatory chronic conditions and
health outcomes, finding significant associations between
symptom severity and reductions in QoL [11,12]. Recent
research also suggests dynamic relationships between in-
flammation and patient affect as a potential mediator of
associations between chronic inflammation and QoL for a
variety of health conditions [13-15].
Literature on specific inflammatory diseases largely
mirrors these general findings concerning inflammatory
disease and QoL. For example, literature on arthritis
documents robust linkage between severity of inflamma-
tion and reductions in QoL, both acutely and over time
[16-24]. This literature also includes research on: asthma
[25]; interstitial cystitis [26-36]; irritable bowel syndrome
[37]; inflammatory bowel disease [37]; chronic ulcerative
colitis [38]; Crohn’s disease [39,40]; non-specific bowel
inflammation [41-44]; chronic prostatitis [45]; vulvuody-
nia [46]; and non-specific genital inflammation [46].
These scholars have focused on a wide range of QoL
outcomes, spanning from self-rated enjoyment of life to
sexual satisfaction to economic livelihood.
Psychosocial mechanisms implicated in the relation-
ship between chronic inflammation and reduced QoL in-
clude: adverse interactional dynamics [47,48]; internal
stress processes [49,50]; emotional strain of coping with
negative social consequences of illness [13,51]; physical,
emotional, and sexual abuse [47,48]; depression [48];
sexual dysfunction [36]; pursuit of “health-related nor-
mality” [52]; fear of having to deal with their symptoms
in public places or in visible ways [43,51]; feelings of iso-
lation and alienation [53,54]; lack of social support from
others [55]; frustration in seeking a diagnosis [50,56].
Comorbidities are common among people with chronic
inflammation [57], and often exacerbate the negative
consequences of inflammation for QoL [35].
Both the literature on generalized inflammation and the
literatures on specific inflammatory diseases as predictors
of QoL indicate that inflammation can cause changes in
QoL. Extant research also suggests that stress can cause
and/or exacerbate inflammation itself [49,50]. Conse-
quently, people whose QoL is already low for reasons not
related to inflammatory pathology may experience higher
levels of inflammation if their life circumstances induce
psychological distress. Overall extant literature indicates
that inflammation can cause reductions in QoL. These re-
ductions may in turn be exacerbated by psychological dis-
tress [8] and resultant increases in allostatic load [58],
creating a vicious cycle of cumulative inequality in health
over time [59].
As suggested previously, diagnosis remains highly
problematic because many people with these diseases go
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that no clinically recognized diagnosis yet exists for their
condition [50,56]. Likewise, many patients who do re-
ceive one diagnosis do not ever learn the full extent of
their condition due to the siloized structure of specialty
medicine in the United States. These issues may affect
women disproportionately, compounding an already sig-
nificant array of disadvantages in health [60,61]. These
studies thus present a strong case for studying associa-
tions between CRP and QoL in lieu of using diagnosis
information.
In studying these associations, scholars should note
that chronic inflammation itself may reflect the influence
of multiple social factors. This is especially true for older
adults [62], as cumulation processes may manifest
strongly [59]. Link and Phelan’s [63] review of advance-
ments in fundamental causation theories supports both
this argument and the idea that social factors may condi-
tion the impacts of inflammation on QoL once present
[63]. The authors illuminate the potential for both ma-
terial and psychosocial resources to impact people’s abil-
ity to cope with disease.
Research on resource multiplication illustrates the poten-
tial for relatively small disadvantages in psychosocial resili-
ency to compound into major consequences for health and
QoL. This reasoning again introduces a cumulation per-
spective that mirrors the “weathering” phenomenon ob-
served in Geronimus and colleagues’ [58,60,61] work on
physical health. Consequently, data on older adults may
offer particular insight into the effects of chronic inflamma-
tion on QoL across the life course. Multiple research teams
[62,64] have conducted meaningful inquiry into chronic in-
flammation among older adults using the National Social
Life, Health, and Aging Project (NSHAP) dataset collected
by Linda Waite and colleagues.
Methods
Data and subject selection
This study uses data from Wave I of the NSHAP. This
biopsychosocial dataset provides information on phys-
ical, mental, and social health among United States resi-
dents aged 57 to 85. Consequently, the NSHAP is an
excellent resource for interdisciplinary scholars of health
and QoL in older adults [65]. This dataset allows re-
searchers to explore the synergistic relationships be-
tween biological, psychological, and social factors that
may influence health status and perceived quality of life.
The NSHAP dataset was developed between 2005 and
2006 by researchers at the University of Chicago. As
such, the NSHAP includes data on 3,005 individuals liv-
ing in and around Chicago, Illinois. Oversampling of
specific demographic groups (African Americans, Lati-
nos, males, and persons 75 to 85 years of age) allows the
dataset to be nationally representative [66]. Data for theNSHAP are collected via a combination of in-home inter-
views, supplemental questionnaires, blood spot blotters,
and saliva cultures. As of Summer 2014 the NSHAP re-
mains essentially cross-sectional, with only two waves of
data available.
Life course sociology literature increasingly suggests
that disadvantage in psychosocial outcomes accumulates
over time from adverse social experience [67-73]. While
the NSHAP data remain largely cross-sectional at present,
the inclusion criteria guarantee at least 57 years elapsed
between birth and data collection for a given subject. Ana-
lyzing an older population cross-sectionally allows re-
searchers to capture long-term impacts from biosocial
exposures that began in early life [67,68]. Consequently,
the NSHAP can illuminate potential cumulation of disad-
vantage in health and QoL from chronic inflammation
due to inherited conditions.
QoL was examined in two different ways: emotionally
(via self-reports of general happiness) and relationally
(via self-reports of overall happiness with intimate rela-
tionships). Extant research suggests that relevant bio-
logical and social predictors may not influence all
domains of QoL equally [74]. In addition, factor analysis
for the two QoL outcomes yielded relatively high values
for uniqueness, suggesting that discrete information
about QoL was captured by each of the two measures.
Assessing different types of QoL thus facilitated broader
inference about the potential impact of chronic inflam-
mation on these outcomes, and the social factors that
may contribute to these patterns.
The main predictor for both QoL outcomes was CRP.
This biomarker has a strong evidence basis supporting
its use in biosocial research on inflammation. CRP also
provides the best evidence of chronic inflammation
among available variables in the NSHAP. In assessing
the potential influence of CRP on QoL, the possible role
of numerous social covariates was also examined as out-
lined in Table 1. These covariates were considered as
both potential confounders of relationships between in-
flammation and QoL, and fundamental causes of inflam-
mation itself.
Using correlational tables, all variables were checked for
unique value as covariates—i.e., low collinearity. Certain
covariates (e.g., feeling able to communicate openly with
intimate partners) also correlated somewhat with one or
both outcome variables. However, this did not present a
methodological problem for two reasons. First, the
NSHAP data documentation explains that the outcome
variable measuring happiness with intimate relationships
captures a variety of factors that may influence this per-
ception, including emotional satisfaction, physical satisfac-
tion, quality of communication, feelings of being able to
rely on another person, and a variety of other elements
[66]. Second, one of the goals of this study was to generate
Table 1 Descriptions and summary statistics for included variables
Construct Variable Units Cases Mean St. Dev. Min. Max.
Quality of life Generally feeling happy Points 2,995 3.58 0.88 1 5
Happiness with relationships 2,890 5.89 1.61 1 7
Chronic inflammation C-reactive protein mg/L 1,939 3.20 6.03 0 100
Sex Female Yes/No 3,005 0.52 0.50 0 1
Male 0.48 0.50
Age Years of age Years 3,005 69.3 7.85 57 85
57 to 64 Yes/No 3,005 0.34 0.47 0 1
65 to 74 0.36 0.48
75 to 85 0.30 0.46
Education Years of education Years 2,971 12.48 4.10 0 32
Less than high school Yes/No 3,005 0.23 0.42 0 1
High school or equivalent 0.26 0.44
Some college 0.28 0.45
Finished college 0.22 0.41
Race White Yes/No 2,993 0.70 0.46 0 1
Any minority 0.30 0.46
Black 0.17 0.38
Hispanic 0.10 0.30
Other race 0.02 0.15
Income Household earnings $/year 2,124 51,264 76,559 0 1,800,000
Social support and communication Open with partner Points 2,012 2.71 0.54 1 3
Open with friends 2,704 2.02 0.73
Relying on family Points 2,793 2.57 0.65 1 3
Relying on friends 2,680 2.30 0.71





Never married 0.04 0.19
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associations between CRP and QoL.
Correlational tables were also used to check for differen-
tial attrition owing to the lack of successful CRP measure-
ments for about 35% of NSHAP participants. Challenges
with inference related to the original measurement strat-
egies in the NSHAP were also noted. For example, the
dataset captures information on sex only as a binary con-
struct. It also does not (despite calling its sex variable
“gender”) collect any information on gender identity.
Assessing possible effects from ethnoracial background
presented similar challenges. Despite the NSHAP’s nation-
ally representative sampling strategy, data could only be
used for participants whose CRP serolevels had beensuccessfully measured. Analyses related to race thus fo-
cused primarily on the potential impact of identifying as a
member of any racial minority group.
As suggested above, some variables in the NSHAP
may have problematic values due to measurement error.
This concern is most pressing for the CRP variable. Al-
though most values are clustered within a range of
10 mg/L, some values are closer to 50 and one person
appears to have a value of 100. Comparing the CRP vari-
able’s median value (1.531 mg/L) to its mean value
(3.19 mg/L) suggests that outliers may be a problem for
this measure. Since CRP levels usually remain in the
single digits even for people with severe inflammation,
these very high values are more likely attributable to
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NSHAP suggests that most implausible measurements on
CRP owe to issues with data collection and processing.
This study was approved by the Florida State Univer-
sity Human Subjects Committee. All data management
and analysis was conducted using Stata Version 12.
Analytic techniques
Net associations between chronic inflammation and QoL
were examined. Hypotheses were tested concerning (1)
potential unique effects of inflammatory pathology on
QoL, and (2) the ability of CRP to mediate associations
between fundamental social determinants and QoL. Rec-
ommendations were developed for further investigation of
these hypotheses in future studies.
Generalized linear modeling techniques, specifically or-
dinal logistic regression, were used to regress QoL out-
comes on CRP. While both QoL variables are numeric
and additive in nature, they do not approximate continuity
because of the relatively limited numbers of response cat-
egories (between 5 and 7) available for each item. Further-
more, QoL data in the NSHAP have significant left skew,
consistent with evidence from the literature that life satis-
faction is often relatively high among older adults [75].
Consequently, either ordinal logistic (ologit) regression
or ordinal probabilistic (oprobit) regression was indi-
cated [74]. Sensitivity analyses using both frameworks
were performed to ensure that results did not differ sub-
stantially; ologit models are presented for ease of inter-
pretation. Models with and without social structure and
relationship covariates (enumerated in Table 1) were
generated to check for potential confounding influences.
Pursuant to the above discussion of parametric versus
non-parametric methods, OLS regression was used to
conduct additional sensitivity analyses, but did not
meaningfully alter findings. Results from non-parametric
methods are thus presented for optimal substantive
validity.
In exploring the potential influence of social structure
and relationship factors, OLS regressions were generated
of CRP on social structure and relationship predictors
respectively. These models built on findings from previ-
ous research [62,64] suggesting that social factors could
fundamentally cause chronic inflammation. Both the
OLS models and the more complex ologit models
allowed for the development of mediation frameworks
for formal analysis in future studies.
Model diagnostics were performed to check regres-
sion assumptions and assess the influence of possible
outlying data. For ologit models, these included likeli-
hood ratio and Wald tests of the proportional odds/par-
allel regression assumption. For OLS models, these
included Breusch-Pagan tests for heteroskedasticity, and
re-estimation of models using Huber-White standarderrors when indicated. Potential outliers were investi-
gated by generating standardized residuals with the
“predict” command and plotting them by case identifi-
cation number. When indicated, models were re-
estimated excluding observations with standardized
residual values greater than 2. While this process often
strengthened findings slightly, unadjusted findings are
presented to maintain conservatism in interpreting
results.
Additional sensitivity analyses were conducted to address
potential problems related to sampling and measurement.
Alternate models were computed using Stata’s “survey”
and/or “cluster” prefixes to incorporate sampling weights.
The “robust” omnibus corrector option was also used to
adjust for a variety of methodological issues. However, nei-
ther of these approaches significantly impacted substantive
findings. This likely owed to the size and diversity of ana-
lytic samples, as well the active incorporation of constructs
addressed by NSHAP sampling weights. Unadjusted results
are thus presented for ease of interpretation.
To compare models with and without statistical con-
trols, fit statistics were computed, including pseudo R-
squared values and information criteria. This helped to
generate hypotheses about whether or not inflammatory
pathology can confer additional effects on QoL in excess
of the social factors that can fundamentally cause
chronic inflammation. Findings from this study recom-
mend exploring chronic inflammation in two distinct
contexts: (1) as a fundamental biological cause of QoL,
and (2) as a mediator in relationships between funda-
mental social determinants and QoL outcomes.
Results
Summary of findings
Ordinal logistic regression models of the two QoL out-
comes on the CRP predictor were generated and exam-
ined. Simply regressing QoL scores on the raw CRP
variable did not prove useful because this general level
of analysis masked more nuanced trends in the data.
Several sets of bivariate models were thus created, using
different methods of coding the CRP variable, using dif-
ferent sets of inclusion criteria for CRP and income, and
using models stratified by different levels of serum CRP.
Rather than attempting to select a single series of final
models, general trends were noted across different inclu-
sion criteria and levels of inflammation. This manuscript
takes a conservative approach to presenting findings. All
values reported come from regressions using the full
sample for each outcome variable, with no additional in-
clusion criteria.
Highly significant negative associations were identified
between CRP levels and both QoL variables. Specifically,
CRP significantly predicted NSHAP participants’ odds of
reporting high levels of general happiness and relationship
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sures mirrored one another in terms of magnitude. When
exponentiated, both raw coefficients for the CRP variable
yielded odds ratios of 0.90 (p < 0.001) for general happi-
ness and 0.92 (p < 0.01) for happiness with relationships.
Among people in the NSHAP sample, each additional
milligram per liter of serum CRP is thus associated with 8
to 10 percent lower odds of experiencing high levels of
QoL when measured either emotionally or relationally.
However, these findings only held true for levels of
CRP below 6 mg/L. These distinctions were explored
using regressions stratified by a 6 mg/L CRP threshold.
Within each group, CRP was preserved as a continuous
independent variable and used to predict QoL. People
with more than 6 mg/L of serum CRP did not exhibit a
significant association between their levels of the inflam-
matory biomarker and QoL on using either outcome
measure. Differences in sample sizes may partially ac-
count for this dichotomy: Samples for the CRP < 6 mg/L
group were 1,683 and 1,626 for emotional and relational
QoL outcomes respectively, versus only 255 and 246 for
the CRP > 6 mg/L group. The discussion section of this
manuscript explores potential (beyond simple sampling
power issues) for which significant relationships were
not observed between CRP and QoL above 6 mg/L.
Ensuing analyses thus focus only on results for people
with less than 6 mg/L of serum CRP. Sample sizes for
each stratum of inflammatory biomarker values are also
displayed. For each outcome, the group of NSHAP partici-
pants with CRP levels below 6 mg/L represented approxi-
mately 87 percent of total variation in inflammatory
biomarker values contained within the full dataset. Indeed,
a growing body of clinical literature on CRP indicates that
stratifying out values in the upper single digits and beyond
can generally capture the vast majority of true variation
within a given study population [62]. Even among older
adults, pronounced inflammatory pathology often appears
at very small numeric values of CRP [62]. Hypotheses were
thus generated about how differences in inflammatory bio-
marker levels may become important sources of social
inequality.
Figures 1a through 2b illustrate graphically how the
probability of reporting different levels of QoL on each
relevant measure varies according to CRP readings.
Figures 1a and 2a show how scores for each outcome
vary according to levels of CRP. By contrast, Figures 1b
and 2b show variation within specific levels of the out-
come variable across different amounts of CRP. Taken
together, these figures illuminate both overall trends and
specific dynamics of how chronic inflammation may im-
pact emotional and relational QoL.
Figures 1a and 2a illustrate that while significant rela-
tionships between CRP serolevels and QoL can be ob-
served for both the emotional and relational measures ofQoL. Figures 1b and 2b add detail by illustrating two
complementary patterns. Higher levels of CRP generally
predict lower odds of reporting high levels of QoL on
each outcome measure. By contrast, lower levels of CRP
predict higher odds of reporting higher levels of QoL.
These graphics also reveal nuances of the observed re-
lationships between inflammatory biomarker levels and
QoL. Specifically, while clear overall correlations (shown
with trendlines) present themselves between CRP and
both QoL outcomes, the curves of best fit for these data
do not closely approximate linearity in either case. So-
ciomedical phenomena that may contribute to these pat-
terns are explored further in the discussion section.
Alternate model specifications
Bivariate models for both outcomes were also re-estimated
incorporating social structural factors. These covariates
represented formal statistical “controls” that could help to
illuminate any potential confounding from structural disad-
vantage. Likewise, significant but non-confounding results
for social structure covariates could illustrate potential fun-
damental causation of chronic inflammation by different
types of disadvantage in social status and position.
Re-estimating models for both outcomes using social
structure and relationship covariates did indeed return
significant results for a variety of social factors. With re-
spect to social structure, both female sex (β = 0.288, p <
0.001) and racial minority identity (β = 0.282, p < 0.01)
predicted higher levels of CRP. By contrast, each add-
itional 10,000 dollars of annual income (β = −0.001, p <
0.05) predicted slightly lower levels of CRP. Additional
years of age did not significantly predict differences in
CRP serolevels. With respect to social relationships, being
married (β = −0.413, p < 0.01) and feeling able to commu-
nicate openly with intimate partners (β = −0.213, p < 0.05)
both predicted lower levels of CRP. Other social relation-
ship factors such as feeling able to communicate openly
with friends, feeling able to rely on family members, and
feeling able to rely on friends did not significantly predict
differences in CRP serolevels.
Yet these results did not generally indicate a con-
founding influence by any of the structural factors
assessed. In fact, some social factors (including race for
the emotional outcome and income for the relational
one) became non-significant when incorporated into
more complex models for each QoL outcome. In gen-
eral, results from computing more complex models sug-
gested that fundamental causation of inflammation by
structural disadvantage was occurring, in addition to
potential independent influences on QoL from these
same factors. Preliminary analyses of fundamental caus-
ation corroborated work by other scholars [62,64] sug-
gesting that disadvantage in a variety of social domains
can fundamentally cause chronic inflammation.
ab
Figure 1 General happiness predicted by inflammatory biomarker levels. (a) Distribution of Emotional QoL Scores by CRP Serolevel.
(b) Probability of Emotional QoL Scores by CRP Serolevel.
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retaining at least some predictive significance was
the relational QoL outcome when modeled incorporat-
ing social relationship factors. Upon incorporating
these covariates, the CRP term became non-significant.
However, the literature suggested that because social
relationship dynamics can change dramatically in re-
sponse to incipent or increasingly severe chronic dis-
ease [54,55] these factors were more likely to mediate
associations between chronic inflammation and QoL
rather than confounding them. Similar patterns ap-
peared with the emotional QoL outcome, for which
CRP remained a significant (albeit less so) predictor in
the full model. Given that QoL outcomes directly ad-
dressing social relationships are likely to respond more
strongly to changes in these dynamics, more sophisti-
cated mediation analyses using longitudinal data
should be conducted in the future.Models were also re-estimated using interaction terms
to check for moderating influences by social structure
factors that showed independently significant relationships
with one or both QoL outcomes. None of these
interaction terms showed any statistical significance when
incorporated into more complex models, and are thus not
presented in depth using tables or graphs. These
null results do not constitute unilateral evidence that
structural disadvantage cannot moderate associations be-
tween chronic inflammation and QoL. Rather, they suggest
that key aspects of social structure likely exert their main
influences farther “upstream” [76] than stages of causation
captured by moderation frameworks. Indeed, as with the
analyses incorporating statistical controls as discussed
above, preliminary moderation analyses merely provided
more support for the idea that social factors can fundamen-
tally cause chronic inflammation—and perhaps also QoL as
a partial function of this inflammatory pathology.
ab
Figure 2 Relationship happiness predicted by inflammatory biomarker levels. (a) Distribution of Relational QoL Scores by CRP Serolevel.
(b) Probability of Relational QoL Scores by CRP Serolevel.
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Implications of key findings
Findings from this study suggest that the progression of
chronic inflammatory disease may exert a significant
negative impact on QoL in both emotional and social
domains. This study establishes a conceptual foundation
that demonstrates the feasibility and importance of con-
ducting more detailed and sophisticated research on the
formative and summative sociomedical dynamics of
chronic inflammation. Likewise, it can help to corrobor-
ate previous research on the fundamental social causes
of inflammation itself, especially findings from other
studies using NSHAP data [62].
While preserving a robust and representative sample of
people in the NSHAP, stratifying my analyses by CRP
levels below and above 6 mg/L also limited the extent to
which outlying values attributable to measurement errorcould skew findings. Using evidence-based stratification
techniques optimized internal validity without dismissing
the potential contributions of very high CRP values to the
overall study results. This facilitated consideration of why
the much smaller samples of people with biomarker levels
greater than 6 mg/L showed no significant associations
between chronic inflammation and QoL, whereas their
peers had markedly different results. As noted previously,
among people with fewer than 6 mg/L of the CRP marker,
chronic inflammation was significantly associated with
both emotional and relational QoL.
Other sociological studies of QoL reflect that different
QoL outcomes may be more or less salient to different
people. They also suggest that depending on the particu-
lar elements of QoL they capture, these same measures
may be more or less sensitive to influence from specific
biological and social forces. When measured using CRP,
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influence people’s overall happiness, as well as their sat-
isfaction in intimate relationships, to a small but consist-
ent degree. Other QoL outcomes may show different
patterns of association with CRP.
This same literature has important implications for the
remainder of my analyses of possible relationships be-
tween CRP and QoL. Any associations documented in
older populations are likely to be more pronounced
among younger groups, as older individuals may expect a
certain amount of decline in health and functionality as a
normal part of the experience of growing older. The social
role of “older adult” in contemporary American society
thus includes changes in physical health and functionality,
despite growing pressure to minimize these changes as
much as possible. Demonstrating evidence of impairment
in the course of performing their prescribed social role
thus affords older adults a certain amount of legitimacy
and credibility, even if they experience very large declines
in health and/or functionality.
Likewise, presenting evidence of diminished health
and/or functionality can lead older adults to begin re-
ceiving assistance, either informally from family mem-
bers or formally from home health professionals. Extant
sociological literature suggests that while people often
experience negative feelings related to loss of independ-
ence when entering into a caregiving arrangement, re-
ceiving care from other people can also exert significant
positive impacts on QoL. Researchers in a variety of dis-
ciplines have documented how living with any type of
persistent illness can produce feelings of isolation and
loneliness, both of which negatively affect QoL. These
feelings can become particularly pronounced for people
who experience a level of functional disability substantial
enough to make living alone difficult, but not severe
enough to warrant seeking outside assistance. Taken to-
gether, these trends may explain why a significant associ-
ation between CRP levels and QoL outcomes did not
emerge for NSHAP participants with CRP levels in ex-
cess of 6 mg/L.
As noted in the results section, visual analysis of
NSHAP data revealed nuances in the relationships be-
tween specific levels of CRP and the odds of reporting
high QoL across both outcome measures. While overall
correlations between CRP and QoL were consistently
negative and clear trendlines emerged, the curves of best
fit for these data did not entirely resemble straight lines.
This may owe in part to measurement considerations,
especially the fact that while higher levels of CRP do
predict chronic inflammation in an overall population,
specific individuals may have levels significantly higher
than average without experiencing significant pathology.
The higher average levels of CRP found among
female-bodied NSHAP participants may speak to thisphenomenon. As noted in the literature review, females
tend to have higher average levels of inflammatory bio-
markers regardless of disease status when compared to
their male peers. However, newer research suggests that
higher levels of CRP in females may owe strongly to
underlying social inequalities that impact females dispro-
portionately [61].
Differences in average levels of CRP among subgroups
within the full NSHAP sample may also stem from so-
ciomedical phenomena related to the lived experience of
chronicity at particular levels of inflammatory pathology.
Across different levels of disease pathology, people’s ex-
pectations for their health and resultant QoL may differ.
Extant literature shows strong associations between cog-
nitive dissonance—the mental anguish people experience
when reality differs unfavorably from expectations—and
reduced QoL among people who develop chronic condi-
tions, including inflammatory diseases.
The fact that social structure factors did not confound
observed relationships between CRP levels and either QoL
outcome indicates that these forces may exert other types
of influences. Fundamental causation [77] of chronic in-
flammation by structural disadvantage is one of the most
likely ways in which these influences may operate. Indeed,
previous research using the NSHAP [62] supports concep-
tualizing chronic inflammation as a socially conditioned
outcome. Likewise, a variety of other studies have shown
strong associations between structural disadvantage and
the onset of different chronic inflammatory conditions
[59,78,79]. Future research should thus analyze inflamma-
tory biomarkers themselves as potential mediators of rela-
tionships between social disadvantage and QoL.
Strengths of this study include background and per-
spectives from multiple disciplines, parsimonious model
specifications, and use of data on older adults. The inter-
disciplinary approach used in this research helps to
bridge gaps in prior work on inflammation, health, social
life, and QoL. As such inquiry into chronic inflamma-
tion’s potential effects on QoL remains relatively new,
parsimonious models were used to guard against report-
ing of significant associations in cases where none were
present. The choice of NSHAP as a data source, and
specifically the advanced ages of its participants, allowed
for insight into potential cumulation of disadvantage in
QoL. This advantage persisted despite the limited num-
ber of waves currently available in the NSHAP.
Limitations of this study include lack of longitudinal data,
challenges with data capture in the NSHAP, and narrow
generalizability. Two specific factors limiting generalizability
are the advanced ages of participants and relatively high
average levels of QoL among these individuals. Only
two waves of NSHAP data are currently available, so
the potential for using panel designs to study these
phenomena remains limited. NSHAP researchers also
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dataset, including the CRP assay. Although this study
accounts for potentially problematic CRP values via
stratification, it is nonetheless possible that some values
in the focal range were also erroneous. Using data on
older adults confers drawbacks in addition to the
advantages noted above. Specifically, the relatively small
range of ages captured by the NSHAP restricts the
generalizability of these findings to late midlife and eld-
erly adulthood. Similar processes may occur in children,
adolescents, and younger adults without manifesting in
the same ways.
Irrespective of the specific strengths and limitations of
a particular study, it should also be noted that no re-
search can unilaterally confirm or refute the potential in-
fluence of chronic inflammation on QoL. Rather, the
statistical significance and reliability of results from this
study lend support to the idea of inflammatory bio-
markers as meaningful correlates of QoL. These findings
likewise recommend further investigation of the topic in
both community and clinical settings.
In addition to their consistent statistical significance,
these findings may indeed possess some clinical signifi-
cance. Specifically, the potential for a 1 mg/L difference
in CRP levels to produce 8 to 10 percent lower odds of
reporting high levels of QoL has important implications
for people’s everyday lives. A person with severe inflam-
matory disease is likely to experience substantially ele-
vated levels of CRP within a certain range [62].
Stratifying regression analyses using a cutoff value of
6 mg/L of CRP allowed for examination of variability
across the vast majority of the analytic sample. For each
computed model, the size of the population group with
CRP serolevels between 0 and 6 mg/L exceeded that of
its counterpart with levels in excess of 6 mg/L by ap-
proximately a factor of 8.
Conclusions
Taken together, findings from analyses of CRP’s potential
net effects on measures of happiness and relationship
satisfaction suggest that chronic inflammation may be
able to exert a significant negative impact on QoL for
older adults. The findings themselves do not constitute
firm evidence of a causal association between CRP levels
and QoL. However, the robust associations documented
between CRP and QoL across a variety of measures indi-
cates that the relationship may be causal, and deserving
of further exploration.
Scholars of aging and health should note that the above
patterns hold true only for community-dwelling older
adults—i.e., the specific population sampled by the
NSHAP. Elderly persons residing in long-term care (LTC)
settings are often discredited and ignored [80]. This can
occur even for residents with extremely strong cognitiveand/or physical functioning [80]. Indeed, persons who
would have been eligible for participation in NSHAP but
moved to long-term care facilities before the study began
were censored from the sample. The potential influence of
chronic inflammation on the social lives and QoL of older
adults in LTC settings thus represents a priority for future
research using other data.
Future research should also contextualize chronic in-
flammation within broader biopsychosocial models of
QoL. Extant research suggests that social factors can act
as fundamental causes [77] of both chronic inflamma-
tion [62,64] and QoL [75]. Specifically, disadvantage in
one or more social domains predicts both increased in-
flammatory biomarker levels [62,64] and reduced QoL
[75]. However, research is needed on whether or not
chronic inflammation can mediate associations between
structural disadvantage and QoL.
Likewise, associations between inflammatory biomarker
levels and QoL may themselves be mediated by additional
social factors. These potential mediating influences should
be explored in future studies. Extant literature provides
ample support for social interaction dynamics as potential
mediators of associations between health status character-
istics and QoL outcomes. For example, trouble in commu-
nicating with intimate partners can intensify the impact of
disadvantage in health on QoL [81,82]. Loss of social sup-
port from friends and family members who become emo-
tionally exhausted may also lead to sharper reductions in
QoL among those with persistent inflammation [83].
Similar interactional factors may also moderate associ-
ations between inflammation and QoL. If the dynamics
of people’s social relationships remain relatively un-
changed by severity of inflammation, then associations
between inflammatory biomarkers and QoL outcomes
may vary according to initial levels of interactional ad-
vantage. For example, people who communicate openly
with their intimate partners may find that dealing with
challenges in health actually brings them closer [16,17].
In turn, social support received from intimate partners
may help to protect health [84] and preserve QoL [85].
Conversely, people in strained relationships may find
that their partners become distant and unsupportive as
their health declines [54,83].
Finally, further research can benefit from incorporat-
ing longitudinal data, as well as more sophisticated
regression frameworks such as Structural Equation
Modeling (SEM). Though only two waves of NSHAP
data are available currently, future research can leverage
panel analysis techniques to illuminate potential
mediation, moderation, and fundamental causation in-
fluences in greater depth. Likewise, techniques such as
SEM can more accurately capture the simultaneous,
synergistic impacts of multiple social and clinical fac-
tors. As more waves of NSHAP data become available,
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more nuanced and comprehensive understanding of
how chronic inflammation may shape QoL in biopsy-
chosocial context.
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